Literature DB >> 15249296

Enhancing public confidence in vaccines through independent oversight of postlicensure vaccine safety.

Daniel A Salmon1, Lawrence H Moulton, Neal A Halsey.   

Abstract

The National Immunization Program of the Centers for Disease Control and Prevention is responsible for controlling infectious diseases through vaccination, but the program also plays a key role in postlicensure vaccine safety assessment. The time has come to separate postlicensure vaccine safety assessment from vaccine risk management as recommended by the National Research Council of the National Academy of Sciences.The National Transportation Safety Board offers a useful model for developing an independent National Vaccine Safety Board that would have the authority to leverage resources and expertise of various government agencies, academia, and industry to oversee postlicensure vaccine safety investigations. Such a board would have been useful in recent vaccine safety concerns, and its independence from government programs would ensure optimal vaccine safety and enhance public confidence in vaccines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15249296      PMCID: PMC1448370          DOI: 10.2105/ajph.94.6.947

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  16 in total

1.  Limiting infant exposure to thimerosal in vaccines and other sources of mercury.

Authors:  N A Halsey
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

2.  More on rotavirus vaccination and intussusception.

Authors:  Trudy V Murphy; Paul M Gargiullo; Melinda Wharton
Journal:  N Engl J Med       Date:  2002-01-17       Impact factor: 91.245

3.  Clinical responses to undiluted and diluted smallpox vaccine.

Authors:  Sharon E Frey; Robert B Couch; Carol O Tacket; John J Treanor; Mark Wolff; Frances K Newman; Robert L Atmar; Robert Edelman; Carrie M Nolan; Robert B Belshe
Journal:  N Engl J Med       Date:  2002-03-28       Impact factor: 91.245

4.  Vaccine risks: real, perceived and unknown.

Authors:  R T Chen
Journal:  Vaccine       Date:  1999-10-29       Impact factor: 3.641

5.  The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA.

Authors:  R T Chen; F DeStefano; R L Davis; L A Jackson; R S Thompson; J P Mullooly; S B Black; H R Shinefield; C M Vadheim; J I Ward; S M Marcy
Journal:  Bull World Health Organ       Date:  2000       Impact factor: 9.408

6.  Intussusception among infants given an oral rotavirus vaccine.

Authors:  T V Murphy; P M Gargiullo; M S Massoudi; D B Nelson; A O Jumaan; C A Okoro; L R Zanardi; S Setia; E Fair; C W LeBaron; M Wharton; J R Livengood; J R Livingood
Journal:  N Engl J Med       Date:  2001-02-22       Impact factor: 91.245

7.  The Vaccine Adverse Event Reporting System (VAERS).

Authors:  R T Chen; S C Rastogi; J R Mullen; S W Hayes; S L Cochi; J A Donlon; S G Wassilak
Journal:  Vaccine       Date:  1994-05       Impact factor: 3.641

8.  National surveillance for Guillain-Barré syndrome: January 1978-March 1979.

Authors:  E S Hurwitz; R C Holman; D B Nelson; L B Schonberger
Journal:  Neurology       Date:  1983-02       Impact factor: 9.910

9.  Smallpox vaccine adverse events among civilians--United States, January 24-February 18, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-02-21       Impact factor: 17.586

10.  The Cutter incident. Poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the Spring of 1955. II. Relationship of poliomyelitis to Cutter vaccine. 1963.

Authors:  N Nathanson; A D Langmuir
Journal:  Am J Epidemiol       Date:  1995-07-15       Impact factor: 4.897

View more
  1 in total

1.  Getting the science right and doing the right science in vaccine safety.

Authors:  Roger Bernier; Karen Midthun
Journal:  Am J Public Health       Date:  2004-06       Impact factor: 9.308

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.